广康生化
(300804)
| 流通市值：9.50亿 | | | 总市值：25.57亿 |
| 流通股本：2750.00万 | | | 总股本：7400.00万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 338,074,642 | 299,676,016.83 | 141,968,780.44 | 201,985,534.49 |
| 交易性金融资产 | 100,694,480 | 50,694,480 | 39,340,050 | 150,492,152.61 |
| 应收票据及应收账款 | 251,283,189.74 | 278,018,997.86 | 209,223,698.17 | 218,688,528.28 |
| 其中：应收票据 | 62,566,571.43 | 53,690,245.48 | 36,105,099.8 | 51,677,177.49 |
| 应收账款 | 188,716,618.31 | 224,328,752.38 | 173,118,598.37 | 167,011,350.79 |
| 应收款项融资 | 2,286,731.3 | 4,117,554.24 | 3,390,239.28 | 4,356,403.76 |
| 预付款项 | 8,659,816.21 | 10,844,776.35 | 25,412,746.01 | 9,820,749.4 |
| 其他应收款合计 | 24,033,753.05 | 3,783,527.58 | 5,223,272.31 | 2,759,018.91 |
| 其中:应收利息 | - | 655,890.41 | - | - |
| 存货 | 345,353,209.32 | 258,651,167.36 | 246,200,839.91 | 221,038,631.8 |
| 其他流动资产 | 70,978,696.64 | 57,745,303.1 | 280,467,154.82 | 279,800,327.9 |
| 流动资产合计 | 1,141,364,518.26 | 963,531,823.32 | 951,226,780.94 | 1,088,941,347.15 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 5,760,000 | - | - | - |
| 固定资产 | 599,115,690.33 | 590,970,970.21 | 580,946,859.04 | 543,695,499.64 |
| 在建工程 | 502,794,444.74 | 474,523,196.51 | 410,526,436.85 | 386,718,875 |
| 使用权资产 | 518,689.25 | 778,033.88 | 1,091,683.22 | 1,364,604.02 |
| 无形资产 | 118,599,903.38 | 144,751,894.76 | 145,624,282.44 | 146,570,190.31 |
| 长期待摊费用 | 7,329,237.19 | 7,947,783.77 | 7,721,227.58 | 4,717,411.27 |
| 递延所得税资产 | 19,991,044.93 | 15,049,780.86 | 13,594,248.64 | 12,294,599.37 |
| 其他非流动资产 | 31,919,976.78 | 21,238,641.6 | 40,912,468.98 | 32,985,322.87 |
| 非流动资产合计 | 1,286,028,986.6 | 1,255,260,301.59 | 1,200,417,206.75 | 1,128,346,502.48 |
| 资产总计 | 2,427,393,504.86 | 2,218,792,124.91 | 2,151,643,987.69 | 2,217,287,849.63 |
| 流动负债: | | | | |
| 短期借款 | 98,917,365.09 | 159,159,061.71 | 144,159,061.71 | 195,987,665.9 |
| 交易性金融负债 | 475,675 | 475,675 | 202,596 | 202,596 |
| 应付票据及应付账款 | 367,415,363.69 | 267,988,956.01 | 242,298,782.51 | 290,563,552.61 |
| 其中：应付票据 | 120,493,883.13 | 63,201,081.48 | 76,970,505.29 | 103,148,264.34 |
| 应付账款 | 246,921,480.56 | 204,787,874.53 | 165,328,277.22 | 187,415,288.27 |
| 合同负债 | 4,277,481.15 | 2,558,755.7 | 7,424,128.73 | 7,538,232.38 |
| 应付职工薪酬 | 11,480,359.86 | 10,641,507.92 | 10,046,586.31 | 14,356,375.87 |
| 应交税费 | 4,279,758.9 | 4,059,965.23 | 2,744,219.83 | 2,834,633.92 |
| 其他应付款合计 | 449,979.84 | 1,480,916.34 | 591,094.33 | 1,223,152.04 |
| 一年内到期的非流动负债 | 79,986,393.69 | 78,564,341.94 | 59,758,554.36 | 56,302,455.1 |
| 其他流动负债 | 67,230,353.63 | 56,012,644.05 | 39,447,970.68 | 67,978,750.24 |
| 流动负债合计 | 634,512,730.85 | 580,941,823.9 | 506,672,994.46 | 636,987,414.06 |
| 非流动负债: | | | | |
| 长期借款 | 419,989,415.64 | 250,228,308.6 | 250,396,441.07 | 186,497,309.55 |
| 预计负债 | - | - | 559,480.82 | - |
| 递延收益 | 23,004,870.11 | 22,326,006.98 | 22,554,863.69 | 22,088,079.48 |
| 递延所得税负债 | 3,041,112.33 | 3,270,633.23 | 3,586,537.02 | 3,615,043.02 |
| 非流动负债合计 | 446,035,398.08 | 275,824,948.81 | 277,097,322.6 | 212,200,432.05 |
| 负债合计 | 1,080,548,128.93 | 856,766,772.71 | 783,770,317.06 | 849,187,846.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 74,000,000 | 74,000,000 | 74,000,000 | 74,000,000 |
| 资本公积 | 846,795,217.4 | 846,795,217.4 | 846,795,217.4 | 846,795,217.4 |
| 其他综合收益 | -1,761.3 | -1,017.57 | - | 0 |
| 专项储备 | 6,220,900.5 | 5,791,533.76 | 5,581,568.49 | 5,425,142.01 |
| 盈余公积 | 53,795,999.01 | 53,795,999.01 | 53,795,999.01 | 53,795,999.01 |
| 未分配利润 | 364,108,037.23 | 379,521,509.15 | 386,739,308.14 | 387,314,767.13 |
| 归属于母公司股东权益合计 | 1,344,918,392.84 | 1,359,903,241.75 | 1,366,912,093.04 | 1,367,331,125.55 |
| 少数股东权益 | 1,926,983.09 | 2,122,110.45 | 961,577.59 | 768,877.97 |
| 股东权益合计 | 1,346,845,375.93 | 1,362,025,352.2 | 1,367,873,670.63 | 1,368,100,003.52 |
| 负债和股东权益合计 | 2,427,393,504.86 | 2,218,792,124.91 | 2,151,643,987.69 | 2,217,287,849.63 |
| 公告日期 | 2026-10-24 | 2026-08-28 | 2026-04-24 | 2026-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |